Allon Therapeutics, Inc.
Neuroscience company to list shares on the Toronto Stock Exchange
Published in Health Business Week, October 21st, 2005
Trading on the TSX will began on September 21, 2005 under the trading symbol NPC.
Gordon McCauley, president and CEO of Allon, said joining the TSX reflects the company's progress as a clinical-stage Canadian biotechnology company developing drugs that protect against conditions such as stroke, traumatic brain injury, Alzheimer disease, multiple sclerosis and neuropathy.
"Our team has consistently added value to Allon's clinical and preclinical portfolio," said McCauley. "We believe our TSX listing reflects this enhanced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2005-10-21)
More Articles from Health Business Week
- Adams Respiratory Therapeutics, Inc.
Mucinex maker reports 161% increase in sales - Applied NeuroSolutions, Inc.
Neuroscience firm reports Richard B. Stone's resignation from its board - Arizona State University
ASU scientists get $3.9 million in grants for neurological disorder research - Athenagen, Inc.
Angiogenesis-focused drug maker raises $5.69M in financing - BioLok International, Inc.
Dental implant maker reports 39% increase in revenues - Caliper Life Sciences, Inc.
LabChip maker names new board member - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
